Medical Aid Guide · South Africa
Does Medical Aid Cover Ozempic or Mounjaro in South Africa?
By Metabolic Doc · Updated April 2026 · 6 min read
Given that GLP-1 medications like Ozempic and Mounjaro can cost R1,500–R4,500 per month, it's a completely legitimate question: will your medical aid help cover the cost? The honest answer is that for most South Africans, for weight management, the answer is currently no — but there are important exceptions, and the landscape is changing.
Quick answer: Most South African medical aids do not cover GLP-1 medications for weight management. However, if you have type 2 diabetes, your scheme may cover Ozempic under a Chronic Disease Benefit. Check with your specific scheme — benefit structures change annually.
Why Most Medical Aids Don't Cover It (Yet)
South African medical aid schemes operate within a framework governed by the Medical Schemes Act and the Council for Medical Schemes (CMS). Key reasons why GLP-1 weight loss coverage is limited:
- Obesity is not a Prescribed Minimum Benefit (PMB) condition. PMBs are the conditions that all medical aids are legally required to cover. Obesity/weight management is not on the PMB list — meaning schemes have no legal obligation to fund treatment.
- Cost concerns. GLP-1 medications are expensive and typically used long-term. Schemes are concerned about the total cost of covering a large proportion of their membership.
- Off-label prescribing complexity. Ozempic is registered for diabetes, not weight loss. Covering its off-label use for weight management requires explicit scheme policy decisions that most have not yet made.
- Changing evidence base. The cardiovascular benefit data (SELECT trial) and growing evidence of obesity as a serious chronic disease are beginning to shift how schemes view this. Coverage may expand in coming years.
What Major Schemes Currently Say
| Medical Aid Scheme | Coverage for Weight Loss (GLP-1) | Coverage for Diabetes (GLP-1) |
| Discovery Health |
Generally no |
Possible (CDB — type 2 diabetes) |
| Bonitas |
Generally no |
Possible (CDB — type 2 diabetes) |
| Medshield |
Generally no |
Check with scheme |
| Momentum Health |
Generally no |
Possible (CDB — type 2 diabetes) |
| Bankmed |
Generally no |
Check with scheme |
| GEMS |
Generally no |
Check with scheme |
* Coverage information is approximate and subject to change. Medical aid benefit structures are reviewed annually. Always confirm directly with your specific scheme and plan option.
This table is a guide, not a definitive answer. Benefit structures change every year, and individual plan options within the same scheme may vary significantly. Always contact your medical aid directly to confirm your current benefits.
How to Check Your Medical Aid Benefits
1
Call your medical aid's clinical team (not the general helpline) and ask specifically: "Does my plan cover semaglutide (Ozempic) or tirzepatide (Mounjaro) for weight management, or for type 2 diabetes management?"
2
Log in to your medical aid's member portal and search the formulary (medication list) for "semaglutide" and "tirzepatide" to see if they're listed and under what conditions.
3
If you have type 2 diabetes, ask specifically about the Chronic Disease Benefit (CDB) and whether your plan option covers Ozempic under this benefit. Provide the nappi code to the pharmacist when dispensing.
4
If denied, ask for the decision in writing and whether an appeal process exists. Some schemes allow clinical motivation from your treating doctor.
What If My Medical Aid Doesn't Cover It?
The majority of GLP-1 weight loss patients in South Africa currently pay out of pocket. Here's how to make this more manageable:
- Use a cash-price pharmacy. Pricing varies significantly between pharmacies. Shop around — independent pharmacies sometimes offer better cash prices than chain pharmacies on GLP-1 medications.
- Discuss medication options with your doctor. Ozempic is generally less expensive than Mounjaro. Starting on Ozempic and switching to Mounjaro if needed is a legitimate, cost-effective approach.
- Consider the total health cost. Reducing obesity-related comorbidities (hypertension, diabetes, sleep apnoea) can reduce your long-term medication burden and potentially lower your overall medical costs.
- Keep a tax record. GLP-1 consultations and medication costs may qualify as medical expenses under SARS Section 6A/6B deductions. Consult your tax advisor.
Will Coverage Improve?
There are genuine reasons for cautious optimism. The medical landscape is evolving rapidly on this issue:
- The SELECT cardiovascular outcomes trial showed semaglutide reduces major adverse cardiovascular events — a compelling argument for scheme coverage, as cardiovascular disease is one of the most expensive conditions to treat.
- International insurers (particularly in the UK, US, and Europe) are increasingly covering GLP-1 therapy as the evidence base mounts.
- The Council for Medical Schemes (CMS) regularly reviews the PMB list — and obesity may be added as clinical and economic evidence grows.
- Several South African schemes have indicated active review of their GLP-1 benefit policies.
We recommend reviewing your benefit schedule each year at renewal and asking your scheme directly about GLP-1 coverage updates.
Frequently Asked Questions
Does medical aid cover Ozempic for weight loss in South Africa?
In general, South African medical aids do not cover Ozempic or other GLP-1 medications for weight management. Some may cover it for type 2 diabetes under a Chronic Disease Benefit. Coverage for weight management specifically is rare, but the landscape may change as evidence grows.
Does Discovery Health cover Ozempic?
Discovery Health may cover Ozempic for members who have type 2 diabetes as a Chronic Disease Benefit (CDB). Coverage for weight management in non-diabetic members is generally not available. Check directly with Discovery for your specific plan.
What is the Chronic Disease Benefit for Ozempic?
The CDB covers medication for Prescribed Minimum Benefit conditions, including type 2 diabetes. Ozempic is registered for type 2 diabetes, so members with this diagnosis may qualify. Weight management is not a PMB-listed condition, so coverage for obesity alone is generally unavailable.
Can I claim back the cost of GLP-1 medications from SARS?
You may be able to claim medical expenses not covered by medical aid as a tax credit under SARS Section 6A/6B. Consultation costs (R700 first visit, R350 renewals) and medication costs may qualify. Keep all receipts and consult your tax advisor for your specific situation.
Find Out If You Qualify — Free
Take our free 2-minute quiz and get a personalised eligibility result before you spend a cent. No medical aid needed.
Take the Free Quiz →